• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在感染滴度达到峰值后,朊病毒神经病理学表现为交替的朊病毒蛋白异构体的积累。

Prion neuropathology follows the accumulation of alternate prion protein isoforms after infective titre has peaked.

作者信息

Sandberg Malin K, Al-Doujaily Huda, Sharps Bernadette, De Oliveira Michael Wiggins, Schmidt Christian, Richard-Londt Angela, Lyall Sarah, Linehan Jacqueline M, Brandner Sebastian, Wadsworth Jonathan D F, Clarke Anthony R, Collinge John

机构信息

MRC Prion Unit and Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK.

出版信息

Nat Commun. 2014 Jul 9;5:4347. doi: 10.1038/ncomms5347.

DOI:10.1038/ncomms5347
PMID:25005024
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4104459/
Abstract

Prions are lethal infectious agents thought to consist of multi-chain forms (PrP(Sc)) of misfolded cellular prion protein (PrP(C)). Prion propagation proceeds in two distinct mechanistic phases: an exponential phase 1, which rapidly reaches a fixed level of infectivity irrespective of PrP(C) expression level, and a plateau (phase 2), which continues until clinical onset with duration inversely proportional to PrP(C) expression level. We hypothesized that neurotoxicity relates to distinct neurotoxic species produced following a pathway switch when prion levels saturate. Here we show a linear increase of proteinase K-sensitive PrP isoforms distinct from classical PrP(Sc) at a rate proportional to PrP(C) concentration, commencing at the phase transition and rising until clinical onset. The unaltered level of total PrP during phase 1, when prion infectivity increases a million-fold, indicates that prions comprise a small minority of total PrP. This is consistent with PrP(C) concentration not being rate limiting to exponential prion propagation and neurotoxicity relating to critical concentrations of alternate PrP isoforms whose production is PrP(C) concentration dependent.

摘要

朊病毒是致死性感染因子,被认为由错误折叠的细胞朊蛋白(PrP(C))的多链形式(PrP(Sc))组成。朊病毒的传播过程分为两个不同的机制阶段:指数期1,无论PrP(C)表达水平如何,感染性都会迅速达到固定水平;平台期(阶段2),持续到临床发病,持续时间与PrP(C)表达水平成反比。我们假设,当朊病毒水平饱和时,神经毒性与途径转换后产生的不同神经毒性物种有关。在此,我们展示了蛋白酶K敏感的PrP异构体的线性增加,这些异构体不同于经典的PrP(Sc),其增加速率与PrP(C)浓度成正比,从相变开始,一直上升到临床发病。在阶段1,当朊病毒感染性增加一百万倍时,总PrP水平未改变,这表明朊病毒在总PrP中只占一小部分。这与PrP(C)浓度不是指数期朊病毒传播的速率限制因素以及神经毒性与替代PrP异构体的临界浓度有关一致,这些异构体的产生依赖于PrP(C)浓度。

相似文献

1
Prion neuropathology follows the accumulation of alternate prion protein isoforms after infective titre has peaked.在感染滴度达到峰值后,朊病毒神经病理学表现为交替的朊病毒蛋白异构体的积累。
Nat Commun. 2014 Jul 9;5:4347. doi: 10.1038/ncomms5347.
2
Prion propagation and toxicity in vivo occur in two distinct mechanistic phases.朊病毒在体内的传播和毒性存在于两个不同的机制阶段。
Nature. 2011 Feb 24;470(7335):540-2. doi: 10.1038/nature09768.
3
Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.朊病毒蛋白疏水结构域内的致病性突变会导致形成具有更高致死率的蛋白酶敏感型朊病毒。
J Virol. 2014 Mar;88(5):2690-703. doi: 10.1128/JVI.02720-13. Epub 2013 Dec 18.
4
Sialylation of prion protein controls the rate of prion amplification, the cross-species barrier, the ratio of PrPSc glycoform and prion infectivity.朊病毒蛋白的唾液酸化作用控制着朊病毒的扩增速率、跨物种屏障、PrPSc糖型比例以及朊病毒的感染性。
PLoS Pathog. 2014 Sep 11;10(9):e1004366. doi: 10.1371/journal.ppat.1004366. eCollection 2014 Sep.
5
Generation of genuine prion infectivity by serial PMCA.通过连续蛋白质错误折叠循环扩增(PMCA)产生真正的朊病毒感染性。
Vet Microbiol. 2007 Aug 31;123(4):346-57. doi: 10.1016/j.vetmic.2007.04.004. Epub 2007 Apr 7.
6
Soluble dimeric prion protein binds PrP(Sc) in vivo and antagonizes prion disease.可溶性二聚体朊病毒蛋白在体内与PrP(Sc)结合并拮抗朊病毒病。
Cell. 2003 Apr 4;113(1):49-60. doi: 10.1016/s0092-8674(03)00201-0.
7
Molecular Mechanism of the Misfolding and Oligomerization of the Prion Protein: Current Understanding and Its Implications.朊病毒蛋白错误折叠和寡聚化的分子机制:当前的认识及其影响
Biochemistry. 2015 Jul 28;54(29):4431-42. doi: 10.1021/acs.biochem.5b00605. Epub 2015 Jul 17.
8
Prion protein functions and dysfunction in prion diseases.朊病毒疾病中朊病毒蛋白的功能与功能障碍
Curr Med Chem. 2009;16(3):380-9. doi: 10.2174/092986709787002673.
9
Protein misfolding cyclic amplification of prions.朊病毒的蛋白质错误折叠循环扩增
J Vis Exp. 2012 Nov 7(69):4075. doi: 10.3791/4075.
10
[Mechanisms of prion transmission].[朊病毒传播机制]
Nihon Rinsho. 2007 Aug;65(8):1391-5.

引用本文的文献

1
Knockout of P2Y12 receptor facilitates neuronal envelopment by reactive microglia and accelerates prion disease.P2Y12受体基因敲除促进反应性小胶质细胞对神经元的包裹并加速朊病毒病。
J Neuroinflammation. 2025 Aug 31;22(1):210. doi: 10.1186/s12974-025-03542-z.
2
Soluble N-terminal region of prion protein causes rapid neurodegeneration in prion disease.朊病毒蛋白的可溶性N端区域在朊病毒病中导致快速神经退行性变。
Sci Adv. 2025 Aug 8;11(32):eadw6867. doi: 10.1126/sciadv.adw6867. Epub 2025 Aug 6.
3
Transient receptor potential vanilloid channel 2 contributes to multi-modal endoplasmic reticulum and perinuclear space dilations that can also be observed in prion-infected mice.

本文引用的文献

1
Prion disease tempo determined by host-dependent substrate reduction.朊病毒病的时间进程由宿主依赖性底物减少决定。
J Clin Invest. 2014 Feb;124(2):847-58. doi: 10.1172/JCI72241. Epub 2014 Jan 16.
2
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases.神经退行性疾病中致病性蛋白聚集物的自我传播。
Nature. 2013 Sep 5;501(7465):45-51. doi: 10.1038/nature12481.
3
A system-level approach for deciphering the transcriptional response to prion infection.一种解析朊病毒感染转录反应的系统方法。
瞬时受体电位香草酸亚型通道2会导致多模式内质网和核周间隙扩张,这种扩张在朊病毒感染的小鼠中也能观察到。
Acta Neuropathol. 2025 Jun 23;149(1):68. doi: 10.1007/s00401-025-02906-2.
4
Microglia-specific NF-κB signaling is a critical regulator of prion-induced glial inflammation and neuronal loss.小胶质细胞特异性核因子κB信号通路是朊病毒诱导的胶质细胞炎症和神经元损失的关键调节因子。
PLoS Pathog. 2025 Jun 18;21(6):e1012582. doi: 10.1371/journal.ppat.1012582. eCollection 2025 Jun.
5
Prion replication in organotypic brain slice cultures is distinct from in vivo inoculation and is species dependent.朊病毒在器官型脑片培养物中的复制不同于体内接种,且具有种属依赖性。
Acta Neuropathol Commun. 2025 Apr 30;13(1):86. doi: 10.1186/s40478-025-01999-w.
6
Investigating the In Vivo Effects of Anti-Prion Protein Nanobodies on Prion Disease with AAV Vector.利用腺相关病毒载体研究抗朊病毒蛋白纳米抗体对朊病毒疾病的体内影响。
Pathogens. 2025 Feb 2;14(2):131. doi: 10.3390/pathogens14020131.
7
Limbic system synaptic dysfunctions associated with prion disease onset.与朊病毒病发病相关的边缘系统突触功能障碍。
Acta Neuropathol Commun. 2024 Dec 20;12(1):192. doi: 10.1186/s40478-024-01905-w.
8
Supportive care or exhausted neglect: the role of microglia at the end stage of prion disease.支持性护理还是疲惫性忽视:小胶质细胞在朊病毒疾病末期的作用
J Clin Invest. 2024 Dec 2;134(23):e186940. doi: 10.1172/JCI186940.
9
Syntaxin-6 delays prion protein fibril formation and prolongs the presence of toxic aggregation intermediates.Syntaxin-6 延迟朊病毒蛋白纤维的形成并延长有毒聚集中间体的存在。
Elife. 2024 Aug 7;13:e83320. doi: 10.7554/eLife.83320.
10
The Role of Glial Cells in Neurobiology and Prion Neuropathology.胶质细胞在神经生物学和朊病毒神经病理学中的作用。
Cells. 2024 May 14;13(10):832. doi: 10.3390/cells13100832.
Bioinformatics. 2011 Dec 15;27(24):3407-14. doi: 10.1093/bioinformatics/btr580. Epub 2011 Oct 20.
4
Prion propagation and toxicity in vivo occur in two distinct mechanistic phases.朊病毒在体内的传播和毒性存在于两个不同的机制阶段。
Nature. 2011 Feb 24;470(7335):540-2. doi: 10.1038/nature09768.
5
Isolation of proteinase K-sensitive prions using pronase E and phosphotungstic acid.使用胰蛋白酶 E 和磷钨酸分离蛋白酶 K 敏感的朊病毒。
PLoS One. 2010 Dec 20;5(12):e15679. doi: 10.1371/journal.pone.0015679.
6
Medicine. Prion strain mutation and selection.医学。朊病毒株突变与选择。
Science. 2010 May 28;328(5982):1111-2. doi: 10.1126/science.1190815.
7
Darwinian evolution of prions in cell culture.在细胞培养中朊病毒的达尔文进化。
Science. 2010 Feb 12;327(5967):869-72. doi: 10.1126/science.1183218. Epub 2009 Dec 31.
8
A systems approach to prion disease.一种针对朊病毒疾病的系统方法。
Mol Syst Biol. 2009;5:252. doi: 10.1038/msb.2009.10. Epub 2009 Mar 24.
9
Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin.用嗜热菌蛋白酶检测和鉴定蛋白酶K敏感的疾病相关朊病毒蛋白
Biochem J. 2008 Dec 1;416(2):297-305. doi: 10.1042/BJ20081235.
10
Molecular diagnosis of human prion disease.人类朊病毒病的分子诊断
Methods Mol Biol. 2008;459:197-227. doi: 10.1007/978-1-59745-234-2_14.